REM Sleep EEG Slowing Linked to Cholinergic Denervation in Older Adults

REM Sleep EEG: A Window into Cholinergic Brain Health

Degeneration of the brain's cholinergic system is a central feature of Alzheimer's disease and Lewy body disease, contributing directly to the decline in memory, attention, and learning [1, 2, 3, 4]. While cholinesterase inhibitors can manage symptoms by increasing acetylcholine availability, the clinical focus is shifting toward identifying individuals in prodromal stages where disease-modifying interventions might be more effective [5, 6, 7, 8]. Because rapid eye movement (REM) sleep is highly dependent on cholinergic activity, disturbances in its architecture and electroencephalogram (EEG) patterns are common in these disorders [9, 4, 8]. A recent study provides new evidence linking specific REM sleep EEG characteristics directly to the integrity of cholinergic innervation in the brain [10].

Measuring Cholinergic Integrity and REM Sleep Patterns

To investigate the link between REM sleep and cholinergic health, the researchers needed precise tools to quantify both. They assessed cholinergic innervation, a measure of the density of cholinergic nerve terminals, using positron emission tomography (PET) with the radioligand [F]-Fluoroethoxybenzovesamicol (FEOBV). This tracer binds specifically to the vesicular acetylcholine transporter, a protein exclusive to cholinergic neurons, allowing the creation of FEOBV-PET standard uptake value ratio maps that visualize cholinergic synaptic density throughout the brain. In parallel, polysomnography was used to capture detailed sleep data. The analysis focused on several metrics, including REM sleep percentage and relative theta power. A key measure was the EEG slowing ratio, calculated as the power of slow waves divided by the power of fast waves ([delta + theta]/[alpha +beta]). This ratio quantifies a shift toward lower-frequency brainwave activity during REM sleep. To map the relationship between these two datasets, the investigators used voxel-wise multiple regressions, a statistical method that examines correlations on a point-by-point basis across a 3D brain map, while controlling for sex to account for potential baseline differences.

Key Associations: EEG Slowing and Cholinergic Loss

The study's primary analysis revealed a significant relationship between brainwave activity during REM sleep and the health of the cholinergic system. The researchers found that higher REM sleep EEG slowing, quantified by the ([delta + theta]/[alpha + beta]) power ratio, was significantly associated with cortical cholinergic denervation. This slowing was observed across multiple scalp locations, including frontal (F3-F4), central (C3-C4), parietal (P3-P4), occipital (O1-O2), and temporal (T5-T6) derivations, indicating a widespread phenomenon. The correlation between EEG slowing and cholinergic loss was most pronounced in brain regions critical for higher-order cognition. Specifically, the association was strongest in fronto-parietal areas, which are involved in executive function and attention, and the medial temporal lobe, which is essential for memory formation. These findings suggest that a global slowing of brainwaves during REM sleep, a measure obtainable through standard EEG, may serve as a sensitive and non-invasive indicator of underlying cholinergic neuron loss in older adults who have not yet developed dementia.

Sex-Specific Patterns of Cholinergic Denervation

An initial analysis of the PET data uncovered an important biological variable: baseline FEOBV uptake was higher in women than in men, suggesting a potential sex difference in cholinergic system density or function. This observation prompted the researchers to conduct exploratory, sex-stratified analyses, adjusted for age, to determine if the relationship between EEG slowing and cholinergic loss differed between men and women. These subsequent analyses revealed distinct anatomical patterns. In women, higher REM sleep EEG slowing ratios were associated with cholinergic denervation primarily in medial temporal regions, areas integral to memory and among the first affected in Alzheimer's disease. In contrast, in men, the same EEG slowing pattern was associated with cholinergic denervation predominantly in neocortical regions. This divergence suggests that while EEG slowing may be a common marker, the underlying anatomical progression of cholinergic loss could differ by sex. Such differences may have future implications for the development and application of sex-specific diagnostic tools or therapeutic strategies.

Clinical Implications for Early Detection and Intervention

The study's findings carry direct clinical relevance for the pursuit of earlier diagnosis in neurodegenerative disease. The authors conclude that global REM sleep EEG slowing may represent a sensitive marker of cortical cholinergic denervation in older adults without dementia. This is a significant observation, as it connects a widely available, non-invasive physiological measurement with a core neuropathological process that typically requires advanced molecular imaging to detect. By providing a potential proxy for cholinergic integrity, REM sleep EEG slowing could become a valuable tool for identifying at-risk individuals before the onset of significant cognitive symptoms. This could, in turn, help clinicians select patients for disease-modifying interventions at a stage when they are most likely to be effective, ultimately improving the prospects for managing conditions like Alzheimer's disease.

References

1. Chen Y, Chen T, Hou R. Locus coeruleus in the pathogenesis of Alzheimer's disease: A systematic review. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2022. doi:10.1002/trc2.12257

2. Hampel H, Mesulam M, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018. doi:10.1093/brain/awy132

3. Okkels N, Grothe MJ, Taylor J, et al. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes. Brain. 2024. doi:10.1093/brain/awae069

4. André C, Martineau‐Dussault M, Daneault V, et al. REM sleep is associated with the volume of the cholinergic basal forebrain in aMCI individuals. Alzheimer s Research & Therapy. 2023. doi:10.1186/s13195-023-01265-y

5. Cani I, Grotteschi N, Calandra-Buonaura G, et al. Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson’s disease without dementia: a systematic review. BMJ Neurology Open. 2025. doi:10.1136/bmjno-2025-001079

6. Kalbe E, Folkerts A, Witt K, Buhmann C, Liepelt‐Scarfone I, Group FTGPG. German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions. Journal of Neurology. 2024. doi:10.1007/s00415-024-12503-0

7. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of Neurology Neurosurgery & Psychiatry. 1999. doi:10.1136/jnnp.66.2.137

8. Stefani A, Antelmi E, Arnaldi D, et al. From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease. Molecular Neurodegeneration. 2025. doi:10.1186/s13024-025-00809-0

9. Zhu R, Xie C, Hu P, Wang K. Clinical variations in Parkinson’s disease patients with or without REM sleep behaviour disorder: a meta-analysis. Scientific Reports. 2017. doi:10.1038/srep40779

10. André C, Bédard M, Daneault V, et al. Associations between REM sleep EEG slowing and brain cholinergic denervation in aging and Mild Cognitive Impairment.. Molecular psychiatry. 2026. doi:10.1038/s41380-026-03635-y